FDA approves trials for ecstasy to help PTSD patients

NeWs 2016-12-01

Views 7

FDA approves trials for ecstasy to help PTSD patients
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
FDA Approves Trials for Ecstasy
play
00:42

FDA Approves Trials for Ecstasy
The FDA Approved Ecstasy Trials as a Treatment for PTSD
play
00:49

The FDA Approved Ecstasy Trials as a Treatment for PTSD
FDA approves first ALS drug in 5 years after pleas from patients - 1breakingnews.com
play
00:23

FDA approves first ALS drug in 5 years after pleas from patients - 1breakingnews.com
FDA approves Relyvrio, the first new ALS drug in five years. Patients had wanted it sooner. - 1break
play
04:45

FDA approves Relyvrio, the first new ALS drug in five years. Patients had wanted it sooner. - 1break
FDA approves Relyvrio, the first new ALS drug in five years. Patients had wanted it sooner. - 1break
play
04:45

FDA approves Relyvrio, the first new ALS drug in five years. Patients had wanted it sooner. - 1break
Trump says FDA approves Gilead's remdesivir drug for coronavirus patients
play
02:32

Trump says FDA approves Gilead's remdesivir drug for coronavirus patients
U.S. FDA approves emergency authorization of convalescent plasma to treat COVID-19 patients
play
00:49

U.S. FDA approves emergency authorization of convalescent plasma to treat COVID-19 patients
U.S. FDA approves emergency authorization of convalescent plasma to treat COVID-19 patients
play
01:34

U.S. FDA approves emergency authorization of convalescent plasma to treat COVID-19 patients
FDA Approves First Novel Schizophrenia Drug in 70 Years, Impacting Up to 3 Million Patients in the US
play
00:40

FDA Approves First Novel Schizophrenia Drug in 70 Years, Impacting Up to 3 Million Patients in the US
FDA approves first ALS drug in 5 years after pleas from patients - 1breakingnews.com
play
00:23

FDA approves first ALS drug in 5 years after pleas from patients - 1breakingnews.com
U.S. FDA approves emergency authorization of convalescent plasma to treat COVID-19 patients
play
02:17

U.S. FDA approves emergency authorization of convalescent plasma to treat COVID-19 patients
U.S. FDA approves continuation of AstraZeneca's Phase III COVID-19 vaccine trials in the U.S.
play
00:51

U.S. FDA approves continuation of AstraZeneca's Phase III COVID-19 vaccine trials in the U.S.